Amulet Capital Raises $1.2 Billion for Healthcare-Focused Fund

New York-based firm targets specialized healthcare investments

Amulet Capital Partners has closed its second fund at $1.2 billion, exceeding its initial target. The New York-based private equity firm focuses on middle-market healthcare companies across sectors such as pharmaceuticals, medical devices, and healthcare services. With this fresh capital, Amulet plans to pursue both growth investments and platform acquisitions, capitalizing on industry consolidation trends. The firm’s previous fund, which raised $670 million, has already yielded strong returns, positioning Amulet as a key player in healthcare private equity. Investors in the new fund include a mix of pension funds, endowments, and family offices.